PCR array screening for gene expression changes in HCC model comparing sorafenib treated or control samples

ABSTRACT: Candidate genes were successfully screened by Cancer PathwayFinder PCR Array Cancer PathwayFinder PCR Array was applied to compare gene changes in xenograft tumor samples of HCC model. A total of 12 samples were examined with 6 from Sorafenib treated group and 6 from control.

ORGANISM(S): Homo sapiens

SUBMITTER: Wei Zhang 

PROVIDER: E-GEOD-33621 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress